The calcineurin inhibitors (CNIs) cyclosporine and tacrolimus have been the cornerstones of immunosuppressive strategies in clinical transplantation. Currently, regimens that are most widely used for induction and maintenance therapy include CNIs. However, many clinical trials aiming at reducing or eliminating CNIs have been performed in recent years. Here, we review and discuss current and future immunosuppressive strategies with a special emphasis on the role of CNIs, in the light of recent studies in the field of kidney transplantation. In the current era, CNIs still play an important role
The goal of research in transplant therapeutics is to achieve safe and effective immunosuppression s...
Introduction The two most significant impediments to renal allograft survival are rejection and the...
The outcome of solid organ transplantation has improved significantly in the past few decades with t...
Although calcineurin inhibitors (CNIs) are effective at preventing a cute rejection, their long-term...
Kidney transplantation is well established as the best treatment option for end-stage kidney disease...
The extensive use of the calcineurininhibitors (CNIs) cyclosporine and tacrolimus as the backbone of...
none2Despite their contribution in the success of organ transplantation, calcineurin inhibitors (CNI...
Introduction: Since 1995, several immunosuppressive drugs have entered the field of organ transplant...
For most patients with chronic kidney failure, kidney transplantation has the greatest potential for...
International audienceLong-term renal transplant outcome is limited by side effects of immunosuppres...
What we CAN do about chronic allograft nephropathy: Role of immunosuppressive modulations Given the ...
Kidney transplantation is considered the best treatment for patients with end-stage renal failure, e...
The calcineurin inhibitors (CNI) cyclosporine and tacrolimus remain the backbone of immunosuppressio...
The two most significant impediments to renal allograft survival are rejection and the direct nephro...
IMMUNOSUPPRESSIVE drugs that are currently in use effectively inhibit the T-lymphocyte–dependent imm...
The goal of research in transplant therapeutics is to achieve safe and effective immunosuppression s...
Introduction The two most significant impediments to renal allograft survival are rejection and the...
The outcome of solid organ transplantation has improved significantly in the past few decades with t...
Although calcineurin inhibitors (CNIs) are effective at preventing a cute rejection, their long-term...
Kidney transplantation is well established as the best treatment option for end-stage kidney disease...
The extensive use of the calcineurininhibitors (CNIs) cyclosporine and tacrolimus as the backbone of...
none2Despite their contribution in the success of organ transplantation, calcineurin inhibitors (CNI...
Introduction: Since 1995, several immunosuppressive drugs have entered the field of organ transplant...
For most patients with chronic kidney failure, kidney transplantation has the greatest potential for...
International audienceLong-term renal transplant outcome is limited by side effects of immunosuppres...
What we CAN do about chronic allograft nephropathy: Role of immunosuppressive modulations Given the ...
Kidney transplantation is considered the best treatment for patients with end-stage renal failure, e...
The calcineurin inhibitors (CNI) cyclosporine and tacrolimus remain the backbone of immunosuppressio...
The two most significant impediments to renal allograft survival are rejection and the direct nephro...
IMMUNOSUPPRESSIVE drugs that are currently in use effectively inhibit the T-lymphocyte–dependent imm...
The goal of research in transplant therapeutics is to achieve safe and effective immunosuppression s...
Introduction The two most significant impediments to renal allograft survival are rejection and the...
The outcome of solid organ transplantation has improved significantly in the past few decades with t...